Department of Lymphoma and Myeloma, MD Anderson Cancer Center
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Division of Cancer Medicine, MD Anderson Cancer Center
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Department of Lymphoma and Myeloma, MD Anderson Cancer Center published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
4 | 1.62 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 4 | 1.62 | |
Cell | 1 | 0.02 | |
Nature Communications | 1 | 0.16 | |
Nature Medicine | 1 | 0.65 | |
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
2020-10-05
|
0.65 | ||
Proceedings of the National Academy of Sciences of the United States of America | 1 | 0.79 |
Top articles by Altmetric score in current window
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Nature Communications
2020-08-26
Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma.
Proceedings of the National Academy of Sciences of the United States of America
2020-08-03

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.